Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 101.00 | |
5 mg | In stock | $ 225.00 | |
10 mg | In stock | $ 326.00 | |
25 mg | In stock | $ 548.00 | |
50 mg | In stock | $ 792.00 | |
100 mg | In stock | $ 1,080.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 233.00 |
Description | JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM. |
Targets&IC50 | VEGFR2:40 nM |
Synonyms | CS-2660 |
Molecular Weight | 364.79 |
Formula | C15H17ClN6O3 |
CAS No. | 951151-97-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/ml (82.24 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-38158471 951151-97-6 Angiogenesis Apoptosis Tyrosine Kinase/Adaptors c-RET VEGFR c-Kit VEGFR-2 cancer SCFR JNJ 38158471 malignancies CS 2660 Kit CD117 RET CS-2660 Vascular endothelial growth factor receptor inhibit CS2660 JNJ38158471 Inhibitor inhibitor